Scarica l'app Stockscreener
17.04
5.25%
0.85
Syndax Pharmaceuticals Inc Borsa (SNDX) Ultime notizie
Point72 Europe London LLP Acquires Shares of 184,683 Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Wellington Management Group LLP Sells 4,198,493 Shares of Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Why is Syndax Pharmaceuticals Inc. stock going downEarnings Growth Summary & Weekly Stock Performance Updates - خودرو بانک
Syndax Pharmaceuticals (NASDAQ:SNDX) Coverage Initiated at Guggenheim - MarketBeat
Trexquant Investment LP Trims Stock Holdings in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
How does Syndax Pharmaceuticals Inc. perform in inflationary periodsJuly 2025 Levels & Real-Time Stock Price Movement Reports - خودرو بانک
What chart patterns are forming on Syndax Pharmaceuticals Inc.July 2025 Selloffs & Entry Point Confirmation Signals - خودرو بانک
Does Syndax Pharmaceuticals Inc. meet Warren Buffett’s criteriaJuly 2025 News Drivers & Technical Buy Zone Confirmation - خودرو بانک
Can Syndax Pharmaceuticals Inc. deliver consistent dividendsJuly 2025 Recap & Fast Moving Market Watchlists - خودرو بانک
Is Syndax Pharmaceuticals Inc. stock a value trapMarket Trend Report & Risk Controlled Daily Plans - خودرو بانک
Invesco Ltd. Has $944,000 Holdings in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Syndax Pharmaceuticals reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | SNDX Stock News - GuruFocus
Syndax Pharmaceuticals' Strategic Use of Inducement Grants to Fuel Long-Term Growth - AInvest
What’s the profit margin of Syndax Pharmaceuticals Inc.2025 EndofYear Setup & Short-Term High Return Strategies - خودرو بانک
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
Signal strength of Syndax Pharmaceuticals Inc. stock in tech scannersJuly 2025 Decliners & Weekly High Potential Stock Alerts - Newser
Is a relief rally coming for Syndax Pharmaceuticals Inc. holdersInsider Buying & Real-Time Stock Price Movement Reports - Newser
Should I trade or invest in Syndax Pharmaceuticals Inc.July 2025 Short Interest & Weekly High Return Stock Opportunities - خودرو بانک
Goldman Sachs Raises Price Target on Syndax Pharmaceuticals (SND - GuruFocus
Does Syndax Pharmaceuticals Inc. have consistent dividend growthJuly 2025 Technicals & Risk Adjusted Swing Trade Ideas - خودرو بانک
Can a trend reversal in Syndax Pharmaceuticals Inc. lead to recoveryJuly 2025 Levels & Real-Time Stock Movement Alerts - Newser
Will Syndax Pharmaceuticals Inc. benefit from macro trendsEarnings Miss & Community Verified Trade Signals - Newser
Palo Alto Investors LP Buys 39,174 Shares of Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Ieq Capital LLC Invests $727,000 in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Will Syndax Pharmaceuticals Inc. continue its uptrendWeekly Trade Report & Weekly Sector Rotation Insights - Newser
Analysts Set Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Target Price at $38.00 - MarketBeat
Will Syndax Pharmaceuticals Inc. benefit from green energy policiesMarket Movers & Expert Approved Trade Ideas - خودرو بانک
Guggenheim initiates Syndax Pharmaceuticals stock with Buy rating on AML drug success - Investing.com Canada
Understanding Syndax Pharmaceuticals Inc.’s price movementWeekly Trend Summary & Smart Money Movement Alerts - Newser
Syndax Pharmaceuticals Inc. (SNDX) Gains Attention with Promising Drug Portfolio and Narrower-than-Expected Q2 Loss - AInvest
Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth - Benzinga
Is this a good reentry point in Syndax Pharmaceuticals Inc.2025 Investor Takeaways & Risk Managed Trade Strategies - Newser
Nuveen LLC Acquires Shares of 224,153 Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Real time breakdown of Syndax Pharmaceuticals Inc. stock performanceGlobal Markets & Long-Term Safe Investment Plans - Newser
Predicting Syndax Pharmaceuticals Inc. trend using moving averagesJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - Newser
What are the future prospects of Syndax Pharmaceuticals Inc.2025 Trading Recap & Daily Oversold Stock Bounce Ideas - خودرو بانک
Can trapped investors hope for a rebound in Syndax Pharmaceuticals Inc.Quarterly Profit Summary & Long-Term Capital Growth Ideas - Newser
Tema Etfs LLC Buys Shares of 21,169 Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
How high can Syndax Pharmaceuticals Inc. stock price go in 2025Market Growth Review & Consistent Profit Trading Strategies - Newser
Syndax Pharmaceuticals Inc. recovery potential after sell offEarnings Growth Report & Trade Opportunity Analysis Reports - Newser
Russell Investments Group Ltd. Has $1.45 Million Stock Holdings in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Statistical indicators supporting Syndax Pharmaceuticals Inc.’s strengthProfit Target & Accurate Intraday Trading Signals - Newser
Smart tools for monitoring Syndax Pharmaceuticals Inc.’s price actionPortfolio Return Report & Precise Trade Entry Recommendations - Newser
Intraday pattern recognizer results for Syndax Pharmaceuticals IncPrice Action & Real-Time Volume Trigger Notifications - Newser
Syndax Pharmaceuticals' Strategic Position in the Evolving Oncology Landscape - AInvest
Is Syndax Pharmaceuticals Inc. still a buy after recent gainsEarnings Overview Summary & Smart Investment Allocation Tips - خودرو بانک
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):